Accelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats

Brain Research

Volumn 826, Issue 2, 1999, Pages 330-334

  Yuan, Li ^a   Han, Zhou ^a   Chang, Jau Kang ^b   Han, Ji Sheng ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b NONE

Author keywords

Amygdala; Cerebroventricular perfusate; Chronic morphine tolerance; Orphanin FQ; Periaqueductal gray; Radioimmunoassay

Indexed keywords

MORPHINE; NOCICEPTIN; OPIATE;

AMYGDALOID NUCLEUS; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG SYNTHESIS; DRUG TOLERANCE; FEMALE; IMMUNOREACTIVITY; NEGATIVE FEEDBACK; NOCICEPTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

AMYGDALA; ANIMALS; BRAIN CHEMISTRY; CEREBRAL VENTRICLES; CHRONIC DISEASE; DRUG TOLERANCE; FEMALE; MORPHINE; MORPHINE DEPENDENCE; NARCOTICS; OPIOID PEPTIDES; PERIAQUEDUCTAL GRAY; RADIOIMMUNOASSAY; RATS; RATS, WISTAR;

EID: 0033135259     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01337-2     Document Type: Article

References (33)

1. Evans C.J., Keith D.E., Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science. 258:1992;1952-1955.
2. Kieffer B.J., Befort K., Gaveriaux-Ruff C., Hirth C.G. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA. 89:1992;12048-12052.
3. Chen Y., Mestek A., Liu J., Hurley J.A., Yu L. Molecular cloning and functional expression of an μ-opioid receptor from rat brain. Mol. Pharmacol. 44:1993;8-12.
4. Thompson R.C., Mansour A., Aki H., Watson S.J. Cloning and pharmacological characterization of a rat μ-opioid receptor. Neuron. 11:1993;903-913.
5. Minami M., Toya T., Katao Y., Maekawa K., Nakamura S., Onogi T., Kaneko S., Satoh M. Cloning and functional expression of a cDNA for the rat kappa-opioid receptor. FEBS Lett. 329:1993;291-295.
6. Meng F., Xie G.X., Thompson R.C., Mansour A., Goldstein A., Watson S.J., Akil H. Cloning and pharmacological characterization of a rat κ opioid receptor. Proc. Natl. Acad. Sci. USA. 90:1993;9954-9958.
7. Mollereau C., Parmentier M., Mailleux P., Butour J.L., Moisand C., Chalon P., Caput D., Vassart G., Meunier J.C. ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
8. Bunzow J.R., Saez C., Mortrud M., Bouvier C., Williams J.T., Low M., Grandy D.K. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ,δ or κ opioid receptor type. FEBS Lett. 341:1994;33-38.
9. Chen Y., Fan Y., Liu J., Mestek A., Tian M., Kozak C.A., Yu L. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett. 347:1994;279-283.
10. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H., Iwabe N., Miyata T., Houtani T., Sugimoto T. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. 343:1994;42-46.
11. Nishi M., Takeshima H., Mori M., Nakagawara K.I., Takeuchi T. Structure and chromosomal mapping of genes for the mouse κ-opioid receptor and an opioid receptor homologue (MOR-C). Biochem. Biophy. Res. Commun. 205:1994;1353-1357.
12. Wick M.J., Minnerath S.R., Lin X., Elde R., Law P.Y., Loh H.H. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned μ, δ, κ opioid receptors. Mol. Brain Res. 27:1994;37-44.
13. Lachowicz J.E., Shen Y., Monsma F.J., Sibley D.R. Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J. Neurochem. 64:1995;34-40.
14. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civelli O. Orphanin FQ: a novel neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 270:1995;792-794.
15. 1 receptor. Nature. 377:1995;532-535.
16. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neurosci. 75:1996;333-337.
17. Tian J.H., Xu W., Fang Y., Mogil J.S., Grisel J.E., Grandy D.K., Han J.S. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br. J. Pharmacol. 120:1997;676-680.
18. Tian J.H., Xu W., Zhang W., Fang Y., Grisel J.E., Mogil J.S., Grandy D.K., Han J.S. Involvement of endogenous orphanin FQ in electroacupuncture-induced analgesia. Neuroreport. 8:1997;497-500.
19. Mogil J.S., Grisel J.E., Zhangs G., Belknap J.K., Grandy D.K. Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ. Neurosci Lett. 214:1996;131-134.
20. Grisel J.E., Mogil J.S., Belknap J.K., Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. Neuroreport. 7:1996;2125-2129.
21. Houtani T., Nishi M., Takeshima H., Nukada T., Sugimoto T. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem. Biophys. Res. Commun. 219:1996;714-719.
22. Northacker H.P., Reinscheid R.K., Mansour A., Henningsen R.A., Ardati A., Monsma F.J., Watson S.J., Civelli O. Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl. Acad. Sci. USA. 93:1996;8677-8682.
23. Tian J.H., Zhang W., Fang Y., Xu W., Grandy D.K., Han J.S. Endogenous orphanin FO: evidence for a role in the modulation of electroacupuncture analgesia and the development of tolerance to analgesia produced by morphine and electroacupuncture. Br. J. Pharmacol. 123:1998;21-26.
24. Anton B., Fein J., To T., Li X., Silberstein L., Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J. Comp. Neurol. 368:1996;229-251.
25. Ren M.F., Han J.S. Rat tail flick acupuncture analgesia model. Chin. Med. J. 92:1979;567-572.
26. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, 1986.
27. Bradford M.M. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
28. Ueda H., Yamaguchi T., Tokuyama S., Inoue M., Nishi M., Takeshima H. Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci Lett. 237:1997;136-138.
29. Yaksh T., Tong L. Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effects within the periaqueductal gray. Brain Res. 114:1976;83-103.
30. Lewis V.A., Gebhart G.F. Evaluation of the periaqueductal central gray (PAG) as a morphine specific locus of action and examination of morphine-induced and stimulation-produced analgesia at coincident PAG loci. Brain Res. 124:1977;283-303.
31. Zhou Z.F., Dong X.Z., Jiang Y., Han J.S. Effect of intracerebral microinjection of naloxone on acupuncture and morphine analgesia in the rabbit. Scientia Sinica. 4:1981;503-511.
32. Morgan M.M., Grisel J.E., Robbins C.S., Grandy D.K. Antinociception medicated by the periaqueductal gray is attenuated by orphanin FQ. Neuroreport. 8:1997;3431-3434.
33. Pu S.F., Han J.S. The central cholecystokinin octapeptide: The site of action for the antiopioid activity and its possible role in morphine tolerance. Prog. Physiol. Sci. 23:1992;149-151.